相似文献
1
Drosophila models of prionopathies: insight into prion protein function, transmission, and neurotoxicity.
Curr Opin Genet Dev. 2017 Jun;44:141-148. doi: 10.1016/j.gde.2017.03.013. Epub 2017 Apr 14.
2
Transcriptional signature of prion-induced neurotoxicity in a Drosophila model of transmissible mammalian prion disease.
Biochem J. 2020 Feb 28;477(4):833-852. doi: 10.1042/BCJ20190872.
3
Y225A induces long-range conformational changes in human prion protein that are protective in Drosophila.
J Biol Chem. 2023 Jul;299(7):104881. doi: 10.1016/j.jbc.2023.104881. Epub 2023 Jun 2.
4
Genetic human prion disease modelled in PrP transgenic .
Biochem J. 2017 Sep 20;474(19):3253-3267. doi: 10.1042/BCJ20170462.
5
D159 and S167 are protective residues in the prion protein from dog and horse, two prion-resistant animals.
Neurobiol Dis. 2018 Nov;119:1-12. doi: 10.1016/j.nbd.2018.07.011. Epub 2018 Jul 24.
6
Prion disease modelled in Drosophila.
Cell Tissue Res. 2023 Apr;392(1):47-62. doi: 10.1007/s00441-022-03586-0. Epub 2022 Jan 29.
7
Structural effects of the highly protective V127 polymorphism on human prion protein.
Commun Biol. 2020 Jul 29;3(1):402. doi: 10.1038/s42003-020-01126-6.
8
Molecular biology and pathology of prion strains in sporadic human prion diseases.
Acta Neuropathol. 2011 Jan;121(1):79-90. doi: 10.1007/s00401-010-0761-3. Epub 2010 Nov 7.
9
Transgenic mice recapitulate the phenotypic heterogeneity of genetic prion diseases without developing prion infectivity: Role of intracellular PrP retention in neurotoxicity.
Prion. 2016 Mar 3;10(2):93-102. doi: 10.1080/19336896.2016.1139276.
10
Familial human prion diseases associated with prion protein mutations Y226X and G131V are transmissible to transgenic mice expressing human prion protein.
Acta Neuropathol Commun. 2018 Feb 20;6(1):13. doi: 10.1186/s40478-018-0516-2.
引用本文的文献
1
Intrinsic determinants of prion protein neurotoxicity in : from sequence to (dys)function.
Front Mol Neurosci. 2023 Aug 14;16:1231079. doi: 10.3389/fnmol.2023.1231079. eCollection 2023.
2
A Reliable Method Based on Liquid Chromatography-Tandem Mass Spectrometry for the Simultaneous Quantification of Neurotransmitters in .
Molecules. 2023 Jul 13;28(14):5373. doi: 10.3390/molecules28145373.
3
as a model to study autophagy in neurodegenerative diseases induced by proteinopathies.
Front Neurosci. 2023 May 18;17:1082047. doi: 10.3389/fnins.2023.1082047. eCollection 2023.
4
The international exchange of Drosophila melanogaster strains.
Rev Sci Tech. 2022 May;41(1):82-90. doi: 10.20506/rst.41.1.3305.
5
Transport of Prions in the Peripheral Nervous System: Pathways, Cell Types, and Mechanisms.
Viruses. 2022 Mar 18;14(3):630. doi: 10.3390/v14030630.
6
New Drosophila models to uncover the intrinsic and extrinsic factors that mediate the toxicity of the human prion protein.
Dis Model Mech. 2022 Apr 1;15(4). doi: 10.1242/dmm.049184. Epub 2022 May 3.
7
Prion disease modelled in Drosophila.
Cell Tissue Res. 2023 Apr;392(1):47-62. doi: 10.1007/s00441-022-03586-0. Epub 2022 Jan 29.
8
as a Model for Infectious Diseases.
Int J Mol Sci. 2021 Mar 8;22(5):2724. doi: 10.3390/ijms22052724.
9
Insight From Animals Resistant to Prion Diseases: Deciphering the Genotype - Morphotype - Phenotype Code for the Prion Protein.
Front Cell Neurosci. 2020 Aug 18;14:254. doi: 10.3389/fncel.2020.00254. eCollection 2020.
10
Role of CPEB3 protein in learning and memory: new insights from synaptic plasticity.
Aging (Albany NY). 2020 Jul 2;12(14):15169-15182. doi: 10.18632/aging.103404.
本文引用的文献
1
A single amino acid (Asp159) from the dog prion protein suppresses the toxicity of the mouse prion protein in Drosophila.
Neurobiol Dis. 2016 Nov;95:204-9. doi: 10.1016/j.nbd.2016.07.025. Epub 2016 Jul 28.
2
Prion Infectivity Plateaus and Conversion to Symptomatic Disease Originate from Falling Precursor Levels and Increased Levels of Oligomeric PrPSc Species.
J Virol. 2015 Dec;89(24):12418-26. doi: 10.1128/JVI.02142-15. Epub 2015 Sep 30.
3
Prion neuropathology follows the accumulation of alternate prion protein isoforms after infective titre has peaked.
Nat Commun. 2014 Jul 9;5:4347. doi: 10.1038/ncomms5347.
4
Prion-induced and spontaneous formation of transmissible toxicity in PrP transgenic Drosophila.
Biochem J. 2014 Oct 1;463(1):31-40. doi: 10.1042/BJ20140129.
5
Distinct tau prion strains propagate in cells and mice and define different tauopathies.
Neuron. 2014 Jun 18;82(6):1271-88. doi: 10.1016/j.neuron.2014.04.047. Epub 2014 May 22.
6
Cytosolic PrP can participate in prion-mediated toxicity.
J Virol. 2014 Jul;88(14):8129-38. doi: 10.1128/JVI.00732-14. Epub 2014 May 7.
7
Prion protein facilitates synaptic vesicle release by enhancing release probability.
Hum Mol Genet. 2014 Sep 1;23(17):4581-96. doi: 10.1093/hmg/ddu171. Epub 2014 Apr 9.
8
Reversible symptoms and clearance of mutant prion protein in an inducible model of a genetic prion disease in Drosophila melanogaster.
Neurobiol Dis. 2014 Jul;67:71-8. doi: 10.1016/j.nbd.2014.03.013. Epub 2014 Mar 28.
9
Combined pharmacological induction of Hsp70 suppresses prion protein neurotoxicity in Drosophila.
PLoS One. 2014 Feb 11;9(2):e88522. doi: 10.1371/journal.pone.0088522. eCollection 2014.
10
Self-propagation of pathogenic protein aggregates in neurodegenerative diseases.
Nature. 2013 Sep 5;501(7465):45-51. doi: 10.1038/nature12481.
Zotero 插件